Biotechnology Assets, S.A. (BME:BST)
Spain flag Spain · Delayed Price · Currency is EUR
0.2160
0.00 (0.00%)
Nov 16, 2026, 3:32 PM CET

Biotechnology Assets Statistics

Total Valuation

BME:BST has a market cap or net worth of EUR 16.19 million. The enterprise value is 16.82 million.

Market Cap16.19M
Enterprise Value 16.82M

Important Dates

The next estimated earnings date is Tuesday, April 6, 2027.

Earnings Date Apr 6, 2027
Ex-Dividend Date n/a

Share Statistics

BME:BST has 74.93 million shares outstanding.

Current Share Class 74.93M
Shares Outstanding 74.93M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) 0.10%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 5.45
PB Ratio 2.63
P/TBV Ratio 3.32
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 5.66
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.21.

Current Ratio 1.35
Quick Ratio 1.35
Debt / Equity 0.21
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11.76

Financial Efficiency

Return on equity (ROE) is -35.89% and return on invested capital (ROIC) is -16.26%.

Return on Equity (ROE) -35.89%
Return on Assets (ROA) -5.46%
Return on Invested Capital (ROIC) -16.26%
Return on Capital Employed (ROCE) -12.20%
Weighted Average Cost of Capital (WACC) 15.09%
Revenue Per Employee 114,786
Profits Per Employee -87,156
Employee Count26
Asset Turnover 0.24
Inventory Turnover n/a

Taxes

In the past 12 months, BME:BST has paid 370,668 in taxes.

Income Tax 370,668
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -29.18% in the last 52 weeks. The beta is 2.11, so BME:BST's price volatility has been higher than the market average.

Beta (5Y) 2.11
52-Week Price Change -29.18%
50-Day Moving Average 0.21
200-Day Moving Average 0.22
Relative Strength Index (RSI) 55.11
Average Volume (20 Days) 278,619

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BME:BST had revenue of EUR 2.98 million and -2.27 million in losses. Loss per share was -0.03.

Revenue2.98M
Gross Profit 2.78M
Operating Income -1.11M
Pretax Income -1.90M
Net Income -2.27M
EBITDA -841,333
EBIT -1.11M
Loss Per Share -0.03
Full Income Statement

Balance Sheet

The company has 688,782 in cash and 1.32 million in debt, with a net cash position of -633,919 or -0.01 per share.

Cash & Cash Equivalents 688,782
Total Debt 1.32M
Net Cash -633,919
Net Cash Per Share -0.01
Equity (Book Value) 6.18M
Book Value Per Share 0.08
Working Capital 987,999
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -657,057 and capital expenditures -981, giving a free cash flow of -658,038.

Operating Cash Flow -657,057
Capital Expenditures -981
Depreciation & Amortization 266,683
Net Borrowing -1.20M
Free Cash Flow -658,038
FCF Per Share -0.01
Full Cash Flow Statement

Margins

Gross margin is 93.09%, with operating and profit margins of -37.13% and -75.93%.

Gross Margin 93.09%
Operating Margin -37.13%
Pretax Margin -63.55%
Profit Margin -75.93%
EBITDA Margin -28.19%
EBIT Margin -37.13%
FCF Margin n/a

Dividends & Yields

BME:BST does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -14.00%
FCF Yield -4.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BME:BST has an Altman Z-Score of -9.57 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -9.57
Piotroski F-Score 5